J. Louise Jones

16.0k total citations
156 papers, 8.1k citations indexed

About

J. Louise Jones is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, J. Louise Jones has authored 156 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cancer Research, 64 papers in Oncology and 58 papers in Molecular Biology. Recurrent topics in J. Louise Jones's work include Cell Adhesion Molecules Research (25 papers), Breast Cancer Treatment Studies (24 papers) and Cancer Cells and Metastasis (23 papers). J. Louise Jones is often cited by papers focused on Cell Adhesion Molecules Research (25 papers), Breast Cancer Treatment Studies (24 papers) and Cancer Cells and Metastasis (23 papers). J. Louise Jones collaborates with scholars based in United Kingdom, United States and Australia. J. Louise Jones's co-authors include Michael D. Allen, Kenneth J. O’Byrne, G. Cox, Rosemary A. Walker, F. Mihaimeed, Iman I. Salama, Peter Bell, Erik Sahai, Cerys Manning and Caroline S. Hill and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

J. Louise Jones

153 papers receiving 7.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Louise Jones United Kingdom 51 3.2k 2.9k 2.3k 1.3k 1.1k 156 8.1k
Steven J. Isakoff United States 37 3.9k 1.2× 5.0k 1.7× 2.8k 1.2× 2.0k 1.6× 1.2k 1.1× 176 9.3k
Hans‐Peter Sinn Germany 47 2.9k 0.9× 3.4k 1.2× 3.3k 1.4× 955 0.8× 597 0.6× 260 8.3k
Kenneth K. Tanabe United States 58 3.2k 1.0× 4.4k 1.5× 1.7k 0.7× 2.0k 1.6× 902 0.9× 236 11.6k
Christoph A. Klein Germany 45 3.4k 1.1× 4.6k 1.6× 3.2k 1.4× 1.3k 1.0× 579 0.5× 152 8.8k
Dennis E. Hallahan United States 66 6.5k 2.1× 3.2k 1.1× 1.9k 0.8× 1.9k 1.6× 592 0.6× 267 13.3k
Ben Davidson Norway 63 6.9k 2.2× 3.8k 1.3× 3.6k 1.5× 2.2k 1.7× 1.1k 1.0× 420 13.7k
Gordon C. Jayson United Kingdom 56 4.7k 1.5× 4.1k 1.4× 2.1k 0.9× 2.1k 1.7× 1.2k 1.1× 257 14.0k
Alnawaz Rehemtulla United States 65 5.1k 1.6× 2.2k 0.8× 1.4k 0.6× 1.9k 1.5× 663 0.6× 232 13.1k
William R. Welch United States 53 5.3k 1.7× 3.1k 1.1× 2.9k 1.2× 1.6k 1.3× 450 0.4× 149 13.6k
Eric O. Aboagye United Kingdom 58 3.9k 1.2× 2.5k 0.8× 2.3k 1.0× 1.9k 1.5× 330 0.3× 336 11.8k

Countries citing papers authored by J. Louise Jones

Since Specialization
Citations

This map shows the geographic impact of J. Louise Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Louise Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Louise Jones more than expected).

Fields of papers citing papers by J. Louise Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Louise Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Louise Jones. The network helps show where J. Louise Jones may publish in the future.

Co-authorship network of co-authors of J. Louise Jones

This figure shows the co-authorship network connecting the top 25 collaborators of J. Louise Jones. A scholar is included among the top collaborators of J. Louise Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Louise Jones. J. Louise Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jahanifar, Mostafa, Lawrence S. Young, Asa Ben‐Hur, et al.. (2023). Cross-linking breast tumor transcriptomic states and tissue histology. Cell Reports Medicine. 4(12). 101313–101313. 2 indexed citations
2.
Allen, Michael D., et al.. (2023). Everybody needs good neighbours: the progressive DCIS microenvironment. Trends in cancer. 9(4). 326–338. 7 indexed citations
3.
Gadaleta, Emanuela, et al.. (2023). Dynamic Biobanking for Advancing Breast Cancer Research. Journal of Personalized Medicine. 13(2). 360–360. 4 indexed citations
4.
Gadaleta, Emanuela, Graeme J. Thorn, Helen Ross‐Adams, J. Louise Jones, & Claude Chelala. (2022). Field cancerization in breast cancer. The Journal of Pathology. 257(4). 561–574. 42 indexed citations
5.
Thorat, Mangesh A., J. Louise Jones, Sarah E. Pinder, et al.. (2021). Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ : Results from the UK/ANZ DCIS Trial. Clinical Cancer Research. 27(10). 2861–2867. 10 indexed citations
6.
Massimi, Lorenzo, Tamara Suaris, Charlotte K. Hagen, et al.. (2021). Volumetric High-Resolution X-Ray Phase-Contrast Virtual Histology of Breast Specimens With a Compact Laboratory System. IEEE Transactions on Medical Imaging. 41(5). 1188–1195. 19 indexed citations
7.
Young, Caroline, Jessica Lee, Mark J. Arends, et al.. (2019). Survey of UK histopathology consultants’ attitudes towards academic and molecular pathology. Journal of Clinical Pathology. 72(6). 399–405. 4 indexed citations
8.
Winters, Zoë, Jonathan Horsnell, Karen T Elvers, et al.. (2018). Systematic review of the impact of breast‐conserving surgery on cancer outcomes of multiple ipsilateral breast cancers. BJS Open. 2(4). 162–174. 24 indexed citations
9.
Carter, Edward, Edmund H. Wilkes, Ann‐Marie Baker, et al.. (2018). PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Reports. 22(9). 2469–2481. 38 indexed citations
10.
Sarper, Müge, Michael D. Allen, Julie Decock, et al.. (2017). Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Breast Cancer Research. 19(1). 33–33. 30 indexed citations
11.
Alexopoulou, Annika N., Colan Ho-Yen, Vassilis Papalazarou, et al.. (2014). Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer. BMC Cancer. 14(1). 237–237. 21 indexed citations
12.
Allen, Michael D., Gareth J. Thomas, Sarah J. Clark, et al.. (2013). Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence. Clinical Cancer Research. 20(2). 344–357. 73 indexed citations
13.
Copson, Ellen, Tom Maishman, Susan M. Gerty, et al.. (2013). Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. British Journal of Cancer. 110(1). 230–241. 56 indexed citations
14.
Novitskaya, Vera, Hanna Romańska, Marwa Dawoud, J. Louise Jones, & Fedor Berditchevski. (2010). Tetraspanin CD151 Regulates Growth of Mammary Epithelial Cells in Three-Dimensional Extracellular Matrix: Implication for Mammary Ductal Carcinoma In situ. Cancer Research. 70(11). 4698–4708. 38 indexed citations
15.
Willis, Lisa, Tomás Alarcón, George Elia, et al.. (2010). Breast Cancer Dormancy Can Be Maintained by Small Numbers of Micrometastases. Cancer Research. 70(11). 4310–4317. 39 indexed citations
16.
Tavora, Bernardo, Stephen D. Robinson, Louise E. Reynolds, et al.. (2010). Endothelial α3β1-Integrin Represses Pathological Angiogenesis and Sustains Endothelial-VEGF. American Journal Of Pathology. 177(3). 1534–1548. 51 indexed citations
17.
Guttery, David S., Simon Hughes, James H. Pringle, et al.. (2010). Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Research. 12(4). R57–R57. 28 indexed citations
18.
Gutiérrez‐Fernández, Ana, Antonio Fueyo, Alicia R. Folgueras, et al.. (2008). Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion. Cancer Research. 68(8). 2755–2763. 154 indexed citations
19.
Yuan, Ming, Romain Lara, Deborah L. Holliday, et al.. (2008). Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death and Differentiation. 15(11). 1752–1759. 271 indexed citations
20.
Cox, G., J. Louise Jones, & Kenneth J. O’Byrne. (2000). Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.. PubMed. 6(6). 2349–55. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven J. Isakoff Breakdown of academic impact, for papers by Hans‐Peter Sinn Breakdown of academic impact, for papers by Kenneth K. Tanabe Breakdown of academic impact, for papers by Christoph A. Klein Breakdown of academic impact, for papers by Dennis E. Hallahan Breakdown of academic impact, for papers by Ben Davidson Breakdown of academic impact, for papers by Gordon C. Jayson Breakdown of academic impact, for papers by Alnawaz Rehemtulla Breakdown of academic impact, for papers by William R. Welch Breakdown of academic impact, for papers by Eric O. Aboagye
Rankless by CCL
2026